Bio-Rad Laboratories
在场
是其中之一......
Bio-Rad Laboratories 是一家在股票代码 BIO (US) 下上市的公司。
高管
查看带有其 25 名主要高管的组织结构图
Bio-Rad Laboratories 搜索最多的简介
- Norman Schwartz, Chairman of the Board, President and Chief Execut...
- Melinda Litherland, Director
- Arnold Pinkston, Director
高管在Bio-Rad Laboratories变化
- Andrew Last, Executive Vice President and Chief Operating Officer, 将于 20249月1 退休 (新闻发布的2024四月12号).
- Roop LakkarajuRoop Lakkaraju 将于20244月15作为 Executive Vice President and Chief Financial Officer 加入公司 (新闻发布的2024三月21号).
- Dara Grantham Wright, Executive Vice President and President of Clinical Diagnostics Group, 将于 20241月12 退休 (新闻发布的2023十二月8号).
创建提醒
跟踪 Bio-Rad Laboratories 的高管变动
医疗设备
Bio-Rad Laboratories 拥有 985 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- Medigus将在Apr 12, 2024将其名称改为Xylo Technologies。 (公布2024四月12号).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (公布2024四月6号).
- Carlsmed 刚刚宣布为 52 筹款数百万美元。 (公布2024三月22号).
医疗设备 行业的其他推荐联系人
消息
Bio-Rad Laboratories 的最新新闻稿
- Bio-Rad Announces Collaboration Agreement with Oncocyte to Commercialize Transplant Monitoring with Droplet Digital PCR
- Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR
- Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
- Bio-Rad Launches Celselect Slides Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
- Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
- Bio-Rad Reports Second-Quarter 2023 Financial Results
- Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
- Bio-Rad Announces New Share Repurchase Program
- Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
- Bio-Rad Publishes Corporate Sustainability Report for 2022
- View more press releases Close
通过电子邮件
